Show simple item record

dc.contributor.authorLouca, Panayiotis
dc.contributor.authorHoorn, Ewout J
dc.contributor.authorMenni, Cristina
dc.contributor.authorPadmanabhan, Sandosh
dc.contributor.authorBeynon-Cobb, Beverley
dc.date.accessioned2023-08-02T10:20:59Z
dc.date.available2023-08-02T10:20:59Z
dc.date.issued2023-03-09
dc.identifier.citationClin J Am Soc Nephrol. 2023 Apr 1;18(4):435-445en_US
dc.identifier.eissn1555-905X
dc.identifier.doi10.2215/CJN.0000000000000119
dc.identifier.pmid36758154
dc.identifier.urihttp://hdl.handle.net/20.500.14200/1550
dc.description.abstractIndividuals with CKD are at a higher risk of cardiovascular morbidity and mortality. Acidosis is positively correlated with CKD progression and elevated systolic BP. Sodium bicarbonate is an efficacious treatment of acidosis, although this may also increase systolic BP. In this systematic review and meta-analysis, we summarize the evidence evaluating systolic BP and antihypertensive medication change (which may indicate systolic BP change) in response to sodium bicarbonate therapy in individuals with CKD.en_US
dc.language.isoenen_US
dc.publisherWolters Kluweren_US
dc.rightsCopyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of American Society of Nephrology.
dc.subjectNephrology/Renal medicineen_US
dc.titleEffect of Sodium Bicarbonate on Systolic Blood Pressure in CKD: A Systematic Review and Meta-Analysis.en_US
dc.typeArticle
dc.source.journaltitleClinical Journal of the American Society of Nephrology
dc.source.volume18
dc.source.issue4
dc.source.beginpage435
dc.source.endpage445
dc.source.countryUnited Kingdom
dc.source.countryUnited Kingdom
dc.source.countryUnited States
rioxxterms.versionNAen_US
dc.contributor.trustauthorBeynon-Cobb, Beverley
dc.contributor.departmentMedicalen_US
dc.contributor.roleAllied Health Professionalen_US
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record